economics

The virtual fishbowl: bringing back dynamic debates to medical conferences
Felix Muehlensiepen, Johanna Mucke, Martin Krusche, Sandra Kurkowski, Gerlinde Bendzuck, Ina Koetter, Vanessa Lemarié, Manuel Grahammer, Martin Heinze, Hendrik Schulze-Koops, Johannes Knitza

Annals of the Rheumatic Diseases May 2021, 80 (5) 675-676; DOI: 10.1136/annrheumdis-2020-219552
Response to: ‘Correspondence on ‘Statistical review: frequently given comments’’ by Waki et al
Stian Lydersen

Annals of the Rheumatic Diseases Mar 2021, annrheumdis-2021-220336; DOI: 10.1136/annrheumdis-2021-220336
Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH Study)
Gary J Macfarlane, Marcus Beasley, Neil Scott, Huey Chong, Paul McNamee, John McBeth, Neil Basu, Philip C Hannaford, Gareth T Jones, Phil Keeley, Gordon J Prescott, Karina Lovell

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219091; DOI: 10.1136/annrheumdis-2020-219091
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
Elise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, N H A M Denissen, Andreas H Gerards, Mike H de Jager, Wai-Kwan Lam-Tse, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong, Jolanda J Luime

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1550-1556; DOI: 10.1136/annrheumdis-2020-217528
Public/private partnerships, at what price?
Maarten Boers

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217664; DOI: 10.1136/annrheumdis-2020-217664

Log in using your username and password

Main menu

Log in using your username and password

You are here

economics